2018-2023 Global Ependymoma Market Report (Status and Outlook)

October 2018 | 138 pages | ID: 22F93E11D47EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Ependymoma market for 2018-2023.

Ependymoma are tissue-based tumors arising from the cells lining the ventricles and central canal within the spinal cord.
Like many tumor types, the exact cause of ependymoma is not known. Unknown causes and lucrative revenue prospects have grabbed attention from big drug makers and thus the market is expected to exhibit significant growth in market value over the forecast years.
United States dominates global ependymoma market followed by Europe due to availability of highly developed healthcare infrastructure and sophisticated treatment technologies.
Asia-Pacific is expected to emerge as promising market for ependymoma due to increasing medical tourism industry, increase in purchasing power, rapidly improving healthcare infrastructure and increased awareness on overall healthcare and available treatments.
Over the next five years, LPI(LP Information) projects that Ependymoma will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares and growth opportunities of Ependymoma market by product type, application, key companies and key regions.

To calculate the market size, LP Information considers value generated from the sales of the following segments:

Segmentation by product type:

• Myxopapillary Ependymomas
• Subependymomas
• Anaplastic Ependymomas

Segmentation by application:

• Children
• Adults

We can also provide the customized separate regional or country-level reports, for the following regions:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

• Eli Lilly
• Astellas
• DNAtrix
• Advantagene
• Burzynski Research Institute
• Direct Therapeutics
• Cellectar Biosciences
• Amgen
• Boehringer Ingelheim
• Bristol-Myers Squibb
• Celgene
• Novartis
• NewLink Genetics

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Ependymoma market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Ependymoma market by identifying its various subsegments.
• Focuses on the key global Ependymoma players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Ependymoma with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the size of Ependymoma submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Ependymoma Market Size 2013-2023
  2.1.2 Ependymoma Market Size CAGR by Region
2.2 Ependymoma Segment by Type
  2.2.1 Myxopapillary Ependymomas
  2.2.2 Subependymomas
  2.2.3 Classic Ependymomas
  2.2.4 Anaplastic Ependymomas
2.3 Ependymoma Market Size by Type
  2.3.1 Global Ependymoma Market Size Market Share by Type (2013-2018)
  2.3.2 Global Ependymoma Market Size Growth Rate by Type (2013-2018)
2.4 Ependymoma Segment by Application
  2.4.1 Children
  2.4.2 Adults
2.5 Ependymoma Market Size by Application
  2.5.1 Global Ependymoma Market Size Market Share by Application (2013-2018)
  2.5.2 Global Ependymoma Market Size Growth Rate by Application (2013-2018)

3 GLOBAL EPENDYMOMA BY PLAYERS

3.1 Global Ependymoma Market Size Market Share by Players
  3.1.1 Global Ependymoma Market Size by Players (2016-2018)
  3.1.2 Global Ependymoma Market Size Market Share by Players (2016-2018)
3.2 Global Ependymoma Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 EPENDYMOMA BY REGIONS

4.1 Ependymoma Market Size by Regions
4.2 Americas Ependymoma Market Size Growth
4.3 APAC Ependymoma Market Size Growth
4.4 Europe Ependymoma Market Size Growth
4.5 Middle East & Africa Ependymoma Market Size Growth

5 AMERICAS

5.1 Americas Ependymoma Market Size by Countries
5.2 Americas Ependymoma Market Size by Type
5.3 Americas Ependymoma Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Ependymoma Market Size by Countries
6.2 APAC Ependymoma Market Size by Type
6.3 APAC Ependymoma Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Ependymoma by Countries
7.2 Europe Ependymoma Market Size by Type
7.3 Europe Ependymoma Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Ependymoma by Countries
8.2 Middle East & Africa Ependymoma Market Size by Type
8.3 Middle East & Africa Ependymoma Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 GLOBAL EPENDYMOMA MARKET FORECAST

10.1 Global Ependymoma Market Size Forecast (2018-2023)
10.2 Global Ependymoma Forecast by Regions
  10.2.1 Global Ependymoma Forecast by Regions (2018-2023)
  10.2.2 Americas Market Forecast
  10.2.3 APAC Market Forecast
  10.2.4 Europe Market Forecast
  10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
  10.3.1 United States Market Forecast
  10.3.2 Canada Market Forecast
  10.3.3 Mexico Market Forecast
  10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
  10.4.1 China Market Forecast
  10.4.2 Japan Market Forecast
  10.4.3 Korea Market Forecast
  10.4.4 Southeast Asia Market Forecast
  10.4.5 India Market Forecast
  10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
  10.5.1 Germany Market Forecast
  10.5.2 France Market Forecast
  10.5.3 UK Market Forecast
  10.5.4 Italy Market Forecast
  10.5.5 Russia Market Forecast
  10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
  10.6.1 Egypt Market Forecast
  10.6.2 South Africa Market Forecast
  10.6.3 Israel Market Forecast
  10.6.4 Turkey Market Forecast
  10.6.5 GCC Countries Market Forecast
10.7 Global Ependymoma Forecast by Type
10.8 Global Ependymoma Forecast by Application

11 KEY PLAYERS ANALYSIS

11.1 Eli Lilly
  11.1.1 Company Details
  11.1.2 Ependymoma Product Offered
  11.1.3 Eli Lilly Ependymoma Revenue, Gross Margin and Market Share (2016-2018)
  11.1.4 Main Business Overview
  11.1.5 Eli Lilly News
11.2 Astellas
  11.2.1 Company Details
  11.2.2 Ependymoma Product Offered
  11.2.3 Astellas Ependymoma Revenue, Gross Margin and Market Share (2016-2018)
  11.2.4 Main Business Overview
  11.2.5 Astellas News
11.3 DNAtrix
  11.3.1 Company Details
  11.3.2 Ependymoma Product Offered
  11.3.3 DNAtrix Ependymoma Revenue, Gross Margin and Market Share (2016-2018)
  11.3.4 Main Business Overview
  11.3.5 DNAtrix News
11.4 Advantagene
  11.4.1 Company Details
  11.4.2 Ependymoma Product Offered
  11.4.3 Advantagene Ependymoma Revenue, Gross Margin and Market Share (2016-2018)
  11.4.4 Main Business Overview
  11.4.5 Advantagene News
11.5 Burzynski Research Institute
  11.5.1 Company Details
  11.5.2 Ependymoma Product Offered
  11.5.3 Burzynski Research Institute Ependymoma Revenue, Gross Margin and Market Share (2016-2018)
  11.5.4 Main Business Overview
  11.5.5 Burzynski Research Institute News
11.6 Direct Therapeutics
  11.6.1 Company Details
  11.6.2 Ependymoma Product Offered
  11.6.3 Direct Therapeutics Ependymoma Revenue, Gross Margin and Market Share (2016-2018)
  11.6.4 Main Business Overview
  11.6.5 Direct Therapeutics News
11.7 Cellectar Biosciences
  11.7.1 Company Details
  11.7.2 Ependymoma Product Offered
  11.7.3 Cellectar Biosciences Ependymoma Revenue, Gross Margin and Market Share (2016-2018)
  11.7.4 Main Business Overview
  11.7.5 Cellectar Biosciences News
11.8 Amgen
  11.8.1 Company Details
  11.8.2 Ependymoma Product Offered
  11.8.3 Amgen Ependymoma Revenue, Gross Margin and Market Share (2016-2018)
  11.8.4 Main Business Overview
  11.8.5 Amgen News
11.9 Boehringer Ingelheim
  11.9.1 Company Details
  11.9.2 Ependymoma Product Offered
  11.9.3 Boehringer Ingelheim Ependymoma Revenue, Gross Margin and Market Share (2016-2018)
  11.9.4 Main Business Overview
  11.9.5 Boehringer Ingelheim News
11.10 Bristol-Myers Squibb
  11.10.1 Company Details
  11.10.2 Ependymoma Product Offered
  11.10.3 Bristol-Myers Squibb Ependymoma Revenue, Gross Margin and Market Share (2016-2018)
  11.10.4 Main Business Overview
  11.10.5 Bristol-Myers Squibb News
11.11 Celgene
11.12 Novartis
11.13 NewLink Genetics

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Table Product Specifications of Ependymoma
Figure Ependymoma Report Years Considered
Figure Market Research Methodology
Figure Global Ependymoma Market Size Growth Rate 2013-2023 ($ Millions)
Table Ependymoma Market Size CAGR by Region 2013-2023 ($ Millions)
Table Major Players of Myxopapillary Ependymomas
Table Major Players of Subependymomas
Table Major Players of Classic Ependymomas
Table Major Players of Anaplastic Ependymomas
Table Market Size by Type (2013-2018) ($ Millions)
Table Global Ependymoma Market Size Market Share by Type (2013-2018)
Figure Global Ependymoma Market Size Market Share by Type (2013-2018)
Figure Global Myxopapillary Ependymomas Market Size Growth Rate
Figure Global Subependymomas Market Size Growth Rate
Figure Global Classic Ependymomas Market Size Growth Rate
Figure Global Anaplastic Ependymomas Market Size Growth Rate
Figure Ependymoma Consumed in Children
Figure Global Ependymoma Market: Children (2013-2018) ($ Millions)
Figure Global Children YoY Growth ($ Millions)
Figure Ependymoma Consumed in Adults
Figure Global Ependymoma Market: Adults (2013-2018) ($ Millions)
Figure Global Adults YoY Growth ($ Millions)
Table Global Ependymoma Market Size by Application (2013-2018) ($ Millions)
Table Global Ependymoma Market Size Market Share by Application (2013-2018)
Figure Global Ependymoma Market Size Market Share by Application (2013-2018)
Figure Global Ependymoma Market Size in Children Growth Rate
Figure Global Ependymoma Market Size in Adults Growth Rate
Table Global Ependymoma Revenue by Players (2016-2018) ($ Millions)
Table Global Ependymoma Revenue Market Share by Players (2016-2018)
Figure Global Ependymoma Revenue Market Share by Players in 2017
Table Global Ependymoma Key Players Head office and Products Offered
Table Ependymoma Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Ependymoma Market Size by Regions 2013-2018 ($ Millions)
Table Global Ependymoma Market Size Market Share by Regions 2013-2018
Figure Global Ependymoma Market Size Market Share by Regions 2013-2018
Figure Americas Ependymoma Market Size 2013-2018 ($ Millions)
Figure APAC Ependymoma Market Size 2013-2018 ($ Millions)
Figure Europe Ependymoma Market Size 2013-2018 ($ Millions)
Figure Middle East & Africa Ependymoma Market Size 2013-2018 ($ Millions)
Table Americas Ependymoma Market Size by Countries (2013-2018) ($ Millions)
Table Americas Ependymoma Market Size Market Share by Countries (2013-2018)
Figure Americas Ependymoma Market Size Market Share by Countries in 2017
Table Americas Ependymoma Market Size by Type (2013-2018) ($ Millions)
Table Americas Ependymoma Market Size Market Share by Type (2013-2018)
Figure Americas Ependymoma Market Size Market Share by Type in 2017
Table Americas Ependymoma Market Size by Application (2013-2018) ($ Millions)
Table Americas Ependymoma Market Size Market Share by Application (2013-2018)
Figure Americas Ependymoma Market Size Market Share by Application in 2017
Figure United States Ependymoma Market Size Growth 2013-2018 ($ Millions)
Figure Canada Ependymoma Market Size Growth 2013-2018 ($ Millions)
Figure Mexico Ependymoma Market Size Growth 2013-2018 ($ Millions)
Table APAC Ependymoma Market Size by Countries (2013-2018) ($ Millions)
Table APAC Ependymoma Market Size Market Share by Countries (2013-2018)
Figure APAC Ependymoma Market Size Market Share by Countries in 2017
Table APAC Ependymoma Market Size by Type (2013-2018) ($ Millions)
Table APAC Ependymoma Market Size Market Share by Type (2013-2018)
Figure APAC Ependymoma Market Size Market Share by Type in 2017
Table APAC Ependymoma Market Size by Application (2013-2018) ($ Millions)
Table APAC Ependymoma Market Size Market Share by Application (2013-2018)
Figure APAC Ependymoma Market Size Market Share by Application in 2017
Figure China Ependymoma Market Size Growth 2013-2018 ($ Millions)
Figure Japan Ependymoma Market Size Growth 2013-2018 ($ Millions)
Figure Korea Ependymoma Market Size Growth 2013-2018 ($ Millions)
Figure Southeast Asia Ependymoma Market Size Growth 2013-2018 ($ Millions)
Figure India Ependymoma Market Size Growth 2013-2018 ($ Millions)
Figure Australia Ependymoma Market Size Growth 2013-2018 ($ Millions)
Table Europe Ependymoma Market Size by Countries (2013-2018) ($ Millions)
Table Europe Ependymoma Market Size Market Share by Countries (2013-2018)
Figure Europe Ependymoma Market Size Market Share by Countries in 2017
Table Europe Ependymoma Market Size by Type (2013-2018) ($ Millions)
Table Europe Ependymoma Market Size Market Share by Type (2013-2018)
Figure Europe Ependymoma Market Size Market Share by Type in 2017
Table Europe Ependymoma Market Size by Application (2013-2018) ($ Millions)
Table Europe Ependymoma Market Size Market Share by Application (2013-2018)
Figure Europe Ependymoma Market Size Market Share by Application in 2017
Figure Germany Ependymoma Market Size Growth 2013-2018 ($ Millions)
Figure France Ependymoma Market Size Growth 2013-2018 ($ Millions)
Figure UK Ependymoma Market Size Growth 2013-2018 ($ Millions)
Figure Italy Ependymoma Market Size Growth 2013-2018 ($ Millions)
Figure Russia Ependymoma Market Size Growth 2013-2018 ($ Millions)
Figure Spain Ependymoma Market Size Growth 2013-2018 ($ Millions)
Table Middle East & Africa Ependymoma Market Size by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Ependymoma Market Size Market Share by Countries (2013-2018)
Figure Middle East & Africa Ependymoma Market Size Market Share by Countries in 2017
Table Middle East & Africa Ependymoma Market Size by Type (2013-2018) ($ Millions)
Table Middle East & Africa Ependymoma Market Size Market Share by Type (2013-2018)
Figure Middle East & Africa Ependymoma Market Size Market Share by Type in 2017
Table Middle East & Africa Ependymoma Market Size by Application (2013-2018) ($ Millions)
Table Middle East & Africa Ependymoma Market Size Market Share by Application (2013-2018)
Figure Middle East & Africa Ependymoma Market Size Market Share by Application in 2017
Figure Egypt Ependymoma Market Size Growth 2013-2018 ($ Millions)
Figure South Africa Ependymoma Market Size Growth 2013-2018 ($ Millions)
Figure Israel Ependymoma Market Size Growth 2013-2018 ($ Millions)
Figure Turkey Ependymoma Market Size Growth 2013-2018 ($ Millions)
Figure GCC Countries Ependymoma Market Size Growth 2013-2018 ($ Millions)
Figure Global Ependymoma arket Size Forecast (2018-2023) ($ Millions)
Table Global Ependymoma Market Size Forecast by Regions (2018-2023) ($ Millions)
Table Global Ependymoma Market Size Market Share Forecast by Regions
Figure Americas Ependymoma Market Size 2018-2023 ($ Millions)
Figure APAC Ependymoma Market Size 2018-2023 ($ Millions)
Figure Europe Ependymoma Market Size 2018-2023 ($ Millions)
Figure Middle East & Africa Ependymoma Market Size 2018-2023 ($ Millions)
Figure United States Ependymoma Market Size 2018-2023 ($ Millions)
Figure Canada Ependymoma Market Size 2018-2023 ($ Millions)
Figure Mexico Ependymoma Market Size 2018-2023 ($ Millions)
Figure Brazil Ependymoma Market Size 2018-2023 ($ Millions)
Figure China Ependymoma Market Size 2018-2023 ($ Millions)
Figure Japan Ependymoma Market Size 2018-2023 ($ Millions)
Figure Korea Ependymoma Market Size 2018-2023 ($ Millions)
Figure Southeast Asia Ependymoma Market Size 2018-2023 ($ Millions)
Figure India Ependymoma Market Size 2018-2023 ($ Millions)
Figure Australia Ependymoma Market Size 2018-2023 ($ Millions)
Figure Germany Ependymoma Market Size 2018-2023 ($ Millions)
Figure France Ependymoma Market Size 2018-2023 ($ Millions)
Figure UK Ependymoma Market Size 2018-2023 ($ Millions)
Figure Italy Ependymoma Market Size 2018-2023 ($ Millions)
Figure Russia Ependymoma Market Size 2018-2023 ($ Millions)
Figure Spain Ependymoma Market Size 2018-2023 ($ Millions)
Figure Egypt Ependymoma Market Size 2018-2023 ($ Millions)
Figure South Africa Ependymoma Market Size 2018-2023 ($ Millions)
Figure Israel Ependymoma Market Size 2018-2023 ($ Millions)
Figure Turkey Ependymoma Market Size 2018-2023 ($ Millions)
Figure GCC Countries Ependymoma Market Size 2018-2023 ($ Millions)
Table Global Ependymoma Market Size Forecast by Type (2018-2023) ($ Millions)
Table Global Ependymoma Market Size Market Share Forecast by Type (2018-2023)
Table Global Ependymoma Market Size Forecast by Application (2018-2023) ($ Millions)
Table Global Ependymoma Market Size Market Share Forecast by Application (2018-2023)
Table Eli Lilly Basic Information, Head Office, Major Market Areas and Its Competitors
Table Eli Lilly Ependymoma Revenue and Gross Margin (2016-2018)
Figure Eli Lilly Ependymoma Market Share (2016-2018)
Table Astellas Basic Information, Head Office, Major Market Areas and Its Competitors
Table Astellas Ependymoma Revenue and Gross Margin (2016-2018)
Figure Astellas Ependymoma Market Share (2016-2018)
Table DNAtrix Basic Information, Head Office, Major Market Areas and Its Competitors
Table DNAtrix Ependymoma Revenue and Gross Margin (2016-2018)
Figure DNAtrix Ependymoma Market Share (2016-2018)
Table Advantagene Basic Information, Head Office, Major Market Areas and Its Competitors
Table Advantagene Ependymoma Revenue and Gross Margin (2016-2018)
Figure Advantagene Ependymoma Market Share (2016-2018)
Table Burzynski Research Institute Basic Information, Head Office, Major Market Areas and Its Competitors
Table Burzynski Research Institute Ependymoma Revenue and Gross Margin (2016-2018)
Figure Burzynski Research Institute Ependymoma Market Share (2016-2018)
Table Direct Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors
Table Direct Therapeutics Ependymoma Revenue and Gross Margin (2016-2018)
Figure Direct Therapeutics Ependymoma Market Share (2016-2018)
Table Cellectar Biosciences Basic Information, Head Office, Major Market Areas and Its Competitors
Table Cellectar Biosciences Ependymoma Revenue and Gross Margin (2016-2018)
Figure Cellectar Biosciences Ependymoma Market Share (2016-2018)
Table Amgen Basic Information, Head Office, Major Market Areas and Its Competitors
Table Amgen Ependymoma Revenue and Gross Margin (2016-2018)
Figure Amgen Ependymoma Market Share (2016-2018)
Table Boehringer Ingelheim Basic Information, Head Office, Major Market Areas and Its Competitors
Table Boehringer Ingelheim Ependymoma Revenue and Gross Margin (2016-2018)
Figure Boehringer Ingelheim Ependymoma Market Share (2016-2018)
Table Bristol-Myers Squibb Basic Information, Head Office, Major Market Areas and Its Competitors
Table Bristol-Myers Squibb Ependymoma Revenue and Gross Margin (2016-2018)
Figure Bristol-Myers Squibb Ependymoma Market Share (2016-2018)
Table Celgene Basic Information, Head Office, Major Market Areas and Its Competitors
Table Novartis Basic Information, Head Office, Major Market Areas and Its Competitors
Table NewLink Genetics Basic Information, Head Office, Major Market Areas and Its Competitors